世界のオフボディ型ウェアラブルインジェクター市場予測（～2028年）：電子インジェクター、機械式インジェクター、その他

• 英文タイトル：Global Off-body Wearable Injectors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8227 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

オフボディ型ウェアラブルインジェクター市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のオフボディ型ウェアラブルインジェクターの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 オフボディ型ウェアラブルインジェクター市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・電子インジェクター、機械式インジェクター、その他 用途別セグメントは次のように区分されます。 ・免疫腫瘍、糖尿病、心血管疾患、その他 世界のオフボディ型ウェアラブルインジェクター市場の主要な市場プレーヤーは以下のとおりです。 ・Becton, Dickinson and Company、Medtronic、Johnson & Johnson、Insulet Corporation、Unilife Corporation、Enable Injections、SteadyMed、Ypsomed Group、West Pharmaceutical Services、Unilife、CeQur、Sensile Medical、Roche、ScPharmaceuticals、SteadyMed 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、オフボディ型ウェアラブルインジェクター製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なオフボディ型ウェアラブルインジェクターメーカーの企業概要、2019年～2022年までのオフボディ型ウェアラブルインジェクターの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なオフボディ型ウェアラブルインジェクターメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別オフボディ型ウェアラブルインジェクターの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのオフボディ型ウェアラブルインジェクターの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのオフボディ型ウェアラブルインジェクター市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびオフボディ型ウェアラブルインジェクターの産業チェーンを掲載しています。 ・第13、14、15章では、オフボディ型ウェアラブルインジェクターの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Becton, Dickinson and Company、Medtronic、Johnson & Johnson、Insulet Corporation、Unilife Corporation、Enable Injections、SteadyMed、Ypsomed Group、West Pharmaceutical Services、Unilife、CeQur、Sensile Medical、Roche、ScPharmaceuticals、SteadyMed ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：電子インジェクター、機械式インジェクター、その他 ・用途別分析2017年-2028年：免疫腫瘍、糖尿病、心血管疾患、その他 ・オフボディ型ウェアラブルインジェクターの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・オフボディ型ウェアラブルインジェクターのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・オフボディ型ウェアラブルインジェクターのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オフボディ型ウェアラブルインジェクターの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・オフボディ型ウェアラブルインジェクターの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Off-body Wearable Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Off-body Wearable Injectors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immuno-oncology accounting for % of the Off-body Wearable Injectors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Electronical Injectors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Off-body Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, and Unilife Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Off-body Wearable Injectors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Electronical Injectors
Mechanical Injectors
Others
Market segment by Application can be divided into
Immuno-oncology
Diabetes
Cardiovascular Diseases
Other
The key market players for global Off-body Wearable Injectors market are listed below:
Becton, Dickinson and Company
Medtronic
Johnson & Johnson
Insulet Corporation
Unilife Corporation
Enable Injections
SteadyMed
Ypsomed Group
West Pharmaceutical Services
Unilife
CeQur
Sensile Medical
Roche
ScPharmaceuticals
SteadyMed
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Off-body Wearable Injectors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Off-body Wearable Injectors, with price, sales, revenue and global market share of Off-body Wearable Injectors from 2019 to 2022.
Chapter 3, the Off-body Wearable Injectors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Off-body Wearable Injectors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Off-body Wearable Injectors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Off-body Wearable Injectors.
Chapter 13, 14, and 15, to describe Off-body Wearable Injectors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Off-body Wearable Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Off-body Wearable Injectors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Off-body Wearable Injectors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Global Off-body Wearable Injectors Market Size & Forecast
1.4.1 Global Off-body Wearable Injectors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Off-body Wearable Injectors Sales in Volume (2017-2028)
1.4.3 Global Off-body Wearable Injectors Price (2017-2028)
1.5 Global Off-body Wearable Injectors Production Capacity Analysis
1.5.1 Global Off-body Wearable Injectors Total Production Capacity (2017-2028)
1.5.2 Global Off-body Wearable Injectors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Off-body Wearable Injectors Market Drivers
1.6.2 Off-body Wearable Injectors Market Restraints
1.6.3 Off-body Wearable Injectors Trends Analysis
2 Manufacturers Profiles
2.1 Becton, Dickinson and Company
2.1.1 Becton, Dickinson and Company Details
2.1.2 Becton, Dickinson and Company Major Business
2.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Product and Services
2.1.4 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Off-body Wearable Injectors Product and Services
2.2.4 Medtronic Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Off-body Wearable Injectors Product and Services
2.3.4 Johnson & Johnson Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Insulet Corporation
2.4.1 Insulet Corporation Details
2.4.2 Insulet Corporation Major Business
2.4.3 Insulet Corporation Off-body Wearable Injectors Product and Services
2.4.4 Insulet Corporation Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Unilife Corporation
2.5.1 Unilife Corporation Details
2.5.2 Unilife Corporation Major Business
2.5.3 Unilife Corporation Off-body Wearable Injectors Product and Services
2.5.4 Unilife Corporation Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Enable Injections
2.6.1 Enable Injections Details
2.6.2 Enable Injections Major Business
2.6.3 Enable Injections Off-body Wearable Injectors Product and Services
2.6.4 Enable Injections Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 SteadyMed
2.7.1 SteadyMed Details
2.7.2 SteadyMed Major Business
2.7.3 SteadyMed Off-body Wearable Injectors Product and Services
2.7.4 SteadyMed Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ypsomed Group
2.8.1 Ypsomed Group Details
2.8.2 Ypsomed Group Major Business
2.8.3 Ypsomed Group Off-body Wearable Injectors Product and Services
2.8.4 Ypsomed Group Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 West Pharmaceutical Services
2.9.1 West Pharmaceutical Services Details
2.9.2 West Pharmaceutical Services Major Business
2.9.3 West Pharmaceutical Services Off-body Wearable Injectors Product and Services
2.9.4 West Pharmaceutical Services Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Unilife
2.10.1 Unilife Details
2.10.2 Unilife Major Business
2.10.3 Unilife Off-body Wearable Injectors Product and Services
2.10.4 Unilife Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 CeQur
2.11.1 CeQur Details
2.11.2 CeQur Major Business
2.11.3 CeQur Off-body Wearable Injectors Product and Services
2.11.4 CeQur Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sensile Medical
2.12.1 Sensile Medical Details
2.12.2 Sensile Medical Major Business
2.12.3 Sensile Medical Off-body Wearable Injectors Product and Services
2.12.4 Sensile Medical Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Roche
2.13.1 Roche Details
2.13.2 Roche Major Business
2.13.3 Roche Off-body Wearable Injectors Product and Services
2.13.4 Roche Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 ScPharmaceuticals
2.14.1 ScPharmaceuticals Details
2.14.2 ScPharmaceuticals Major Business
2.14.3 ScPharmaceuticals Off-body Wearable Injectors Product and Services
2.14.4 ScPharmaceuticals Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 SteadyMed
2.15.1 SteadyMed Details
2.15.2 SteadyMed Major Business
2.15.3 SteadyMed Off-body Wearable Injectors Product and Services
2.15.4 SteadyMed Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Off-body Wearable Injectors Breakdown Data by Manufacturer
3.1 Global Off-body Wearable Injectors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Off-body Wearable Injectors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Off-body Wearable Injectors
3.4 Market Concentration Rate
3.4.1 Top 3 Off-body Wearable Injectors Manufacturer Market Share in 2021
3.4.2 Top 6 Off-body Wearable Injectors Manufacturer Market Share in 2021
3.5 Global Off-body Wearable Injectors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Off-body Wearable Injectors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Off-body Wearable Injectors Market Size by Region
4.1.1 Global Off-body Wearable Injectors Sales in Volume by Region (2017-2028)
4.1.2 Global Off-body Wearable Injectors Revenue by Region (2017-2028)
4.2 North America Off-body Wearable Injectors Revenue (2017-2028)
4.3 Europe Off-body Wearable Injectors Revenue (2017-2028)
4.4 Asia-Pacific Off-body Wearable Injectors Revenue (2017-2028)
4.5 South America Off-body Wearable Injectors Revenue (2017-2028)
4.6 Middle East and Africa Off-body Wearable Injectors Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Off-body Wearable Injectors Sales in Volume by Type (2017-2028)
5.2 Global Off-body Wearable Injectors Revenue by Type (2017-2028)
5.3 Global Off-body Wearable Injectors Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Off-body Wearable Injectors Sales in Volume by Application (2017-2028)
6.2 Global Off-body Wearable Injectors Revenue by Application (2017-2028)
6.3 Global Off-body Wearable Injectors Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Off-body Wearable Injectors Sales by Type (2017-2028)
7.2 North America Off-body Wearable Injectors Sales by Application (2017-2028)
7.3 North America Off-body Wearable Injectors Market Size by Country
7.3.1 North America Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
7.3.2 North America Off-body Wearable Injectors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Off-body Wearable Injectors Sales by Type (2017-2028)
8.2 Europe Off-body Wearable Injectors Sales by Application (2017-2028)
8.3 Europe Off-body Wearable Injectors Market Size by Country
8.3.1 Europe Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
8.3.2 Europe Off-body Wearable Injectors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Off-body Wearable Injectors Sales by Type (2017-2028)
9.2 Asia-Pacific Off-body Wearable Injectors Sales by Application (2017-2028)
9.3 Asia-Pacific Off-body Wearable Injectors Market Size by Region
9.3.1 Asia-Pacific Off-body Wearable Injectors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Off-body Wearable Injectors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Off-body Wearable Injectors Sales by Type (2017-2028)
10.2 South America Off-body Wearable Injectors Sales by Application (2017-2028)
10.3 South America Off-body Wearable Injectors Market Size by Country
10.3.1 South America Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
10.3.2 South America Off-body Wearable Injectors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Off-body Wearable Injectors Sales by Type (2017-2028)
11.2 Middle East & Africa Off-body Wearable Injectors Sales by Application (2017-2028)
11.3 Middle East & Africa Off-body Wearable Injectors Market Size by Country
11.3.1 Middle East & Africa Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Off-body Wearable Injectors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Off-body Wearable Injectors and Key Manufacturers
12.2 Manufacturing Costs Percentage of Off-body Wearable Injectors
12.3 Off-body Wearable Injectors Production Process
12.4 Off-body Wearable Injectors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Off-body Wearable Injectors Typical Distributors
13.3 Off-body Wearable Injectors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---